These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 4786756)

  • 41. Severe theophylline intoxication: a delay in charcoal haemoperfusion solved by oral activated charcoal.
    Rutten J; van den Berg B; van Gelder T; van Saase J
    Nephrol Dial Transplant; 2005 Dec; 20(12):2868-9. PubMed ID: 16115857
    [No Abstract]   [Full Text] [Related]  

  • 42. Proceedings: Bioavailability of salicylamide from tablets.
    Mulley BA; Rye RM; Shaw P
    J Pharm Pharmacol; 1973 Dec; 25():Suppl:150P. PubMed ID: 4150555
    [No Abstract]   [Full Text] [Related]  

  • 43. Antidotal properties of activated charcoal.
    Henschler D
    Arh Hig Rada Toksikol; 1970; 21(2):129-36. PubMed ID: 5511986
    [No Abstract]   [Full Text] [Related]  

  • 44. Experimental study of the migration of charcoal particles in the human mouth.
    Jenkins GN; Krebsbach PH
    Arch Oral Biol; 1985; 30(9):697-9. PubMed ID: 3865647
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Removal of endogenous and exogenous toxins by a microencapsulated absorbent.
    Chang TM
    Can J Physiol Pharmacol; 1969 Dec; 47(12):1043-5. PubMed ID: 5360363
    [No Abstract]   [Full Text] [Related]  

  • 46. [Investigations on preparation and properties of tablets; example of a re-assay of a tablet prescription; Carbo adsorbens granulatus].
    MUNZEL K; AKAY K
    Pharm Acta Helv; 1951 Sep; 26(9):277-84. PubMed ID: 14882927
    [No Abstract]   [Full Text] [Related]  

  • 47. Evaluation of five activated charcoal formulations for inhibition of aspirin absorption and palatability in man.
    Scholtz EC; Jaffe JM; Colaizzi JL
    Am J Hosp Pharm; 1978 Nov; 35(11):1355-9. PubMed ID: 707504
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparison of the adsorption capacities of an activated-charcoal--yogurt mixture versus activated-charcoal--water slurry in vivo and in vitro.
    Hoegberg LC; Christophersen AB; Christensen HR; Angelo HR
    Clin Toxicol (Phila); 2005; 43(4):269-75. PubMed ID: 16035203
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug adsorption efficacy and palatability of a novel charcoal cookie formulation.
    Klein-Schwartz W; Doyon S; Dowling T
    Pharmacotherapy; 2010 Sep; 30(9):888-94. PubMed ID: 20795844
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative antidotal efficacy of activated charcoal tablets, capsules and suspension in healthy volunteers.
    Remmert HP; Olling M; Slob W; van der Giesen WF; van Dijk A; Rauws AG
    Eur J Clin Pharmacol; 1990; 39(5):501-5. PubMed ID: 2076744
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Activated charcoal in the treatment of acute drug poisonings].
    Christophersen AB; Hilsted LM; Christensen HR
    Ugeskr Laeger; 1999 Oct; 161(40):5559-63. PubMed ID: 10553373
    [No Abstract]   [Full Text] [Related]  

  • 52. [The significance of the form of preparation for the degree of adsorption of medical charcoal].
    Otto U; Stenberg B
    Lakartidningen; 1973 Aug; 70(31):2729-30. PubMed ID: 4786756
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.